Jeffrey M. Dayno - Oct 6, 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: Chief Medical Officer
Signature: /s/ Christian Ulrich, Attorney-in-fact
Stock symbol: HRMY
Transactions as of: Oct 6, 2021
Transactions value $: -$57,383
Form type: 4
Date filed: 10/7/2021, 06:55 PM
Previous filing: Sep 9, 2021
Next filing: Oct 20, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$14.8K	+1.8K		$8.22^*	1.8K	Oct 6, 2021	Direct
transaction	HRMY	Common Stock	Sale	-$72.2K	-1.8K	-100%	$40.10	0	Oct 6, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Stock Option	Options Exercise	$0	-1.8K	-2.45%	$0.00	71.7K	Oct 6, 2021	Common Stock	1.8K	$8.22	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.075 to $40.41. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The stock option is currently vested with respect to 62,082 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on November 1, 2021.